VIDA (Discovery Tools) Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
164
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
23
VIDA (Discovery Tools) General Information
Description
Operator of a lung health company delivering artificial intelligence-powered lung intelligence intended to accelerate new therapies to patients. The company's platform offers a full suite of clinical trial services, including advanced quantitative image analysis, providing healthcare professionals with trial data, site quality services, subject screening, and other related services.
Contact Information
Website
www.vidalung.aiCorporate Office
- 2500 Crosspark Road
- W250 BioVentures Center
- Coralville, IA 52241
- United States
Corporate Office
- 2500 Crosspark Road
- W250 BioVentures Center
- Coralville, IA 52241
- United States
VIDA (Discovery Tools) Timeline
VIDA (Discovery Tools) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 16. Debt - General | Completed | Generating Revenue | ||||
| 15. Later Stage VC (Series D) | 29-Sep-2023 | Completed | Generating Revenue | |||
| 14. Debt - General | 01-Apr-2022 | Completed | Generating Revenue | |||
| 13. Debt - PPP | 15-Apr-2020 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series C) | 09-Apr-2020 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series B1) | 01-Jan-2017 | Completed | Generating Revenue | |||
| 10. Grant | 13-Dec-2016 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 07-Dec-2016 | $6.14M | $8.5M | Completed | Generating Revenue | |
| 8. Grant | 01-Jan-2015 | $500K | $2.36M | Completed | Generating Revenue |
VIDA (Discovery Tools) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D2 | ||||||||
| Series D1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 312,500 | $0.000100 | $0.2 | $4 | $4 | 1x | $2.58 | 1.63% |
| Series A | 529,046 | $0.000100 | $0.1 | $2.1 | $2.1 | 1x | $1.72 | 2.17% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
VIDA (Discovery Tools) Comparisons
Industry
Financing
Details
VIDA (Discovery Tools) Competitors (20)
One of VIDA (Discovery Tools)’s 20 competitors is Unlearn, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Unlearn | Venture Capital-Backed | San Francisco, CA | ||||
| Gene By Gene | Formerly VC-backed | Houston, TX | ||||
| DeepSight | Venture Capital-Backed | Clayton, MO | ||||
| Thirona | Venture Capital-Backed | Nijmegen, Netherlands | ||||
| Aidoc | Venture Capital-Backed | Tel Aviv, Israel |
VIDA (Discovery Tools) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
VIDA (Discovery Tools) Patents
VIDA (Discovery Tools) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240386552-A1 | Method of quantifying lung disease | Pending | 18-May-2023 | ||
| US-20230363730-A1 | Airway mucus visualization | Pending | 13-May-2022 | ||
| US-20220172367-A1 | Visualization of sub-pleural regions | Active | 27-Nov-2020 | ||
| US-12266111-B2 | Visualization of sub-pleural regions | Active | 27-Nov-2020 | ||
| US-20220130040-A1 | Pulmonary analysis using transpulmonary pressure | Active | 27-Oct-2020 | G06T7/0012 |
VIDA (Discovery Tools) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
VIDA (Discovery Tools) Investors (23)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| InnoVenture Iowa | Venture Capital | Minority | ||
| Listwin Ventures | Venture Capital | Minority | ||
| Mathers Associates | Corporation | Minority | ||
| University of Wisconsin Health | Corporation | Minority | ||
| Blue Heron Capital | Growth/Expansion | Minority |
VIDA (Discovery Tools) FAQs
-
When was VIDA (Discovery Tools) founded?
VIDA (Discovery Tools) was founded in 2004.
-
Where is VIDA (Discovery Tools) headquartered?
VIDA (Discovery Tools) is headquartered in Coralville, IA.
-
What is the size of VIDA (Discovery Tools)?
VIDA (Discovery Tools) has 164 total employees.
-
What industry is VIDA (Discovery Tools) in?
VIDA (Discovery Tools)’s primary industry is Discovery Tools (Healthcare).
-
Is VIDA (Discovery Tools) a private or public company?
VIDA (Discovery Tools) is a Private company.
-
What is VIDA (Discovery Tools)’s current revenue?
The current revenue for VIDA (Discovery Tools) is .
-
How much funding has VIDA (Discovery Tools) raised over time?
VIDA (Discovery Tools) has raised $44.2M.
-
Who are VIDA (Discovery Tools)’s investors?
InnoVenture Iowa, Listwin Ventures, Mathers Associates, University of Wisconsin Health, and Blue Heron Capital are 5 of 23 investors who have invested in VIDA (Discovery Tools).
-
Who are VIDA (Discovery Tools)’s competitors?
Unlearn, Gene By Gene, DeepSight, Thirona, and Aidoc are some of the 20 competitors of VIDA (Discovery Tools).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
